David Riches
Concepts (395)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Idiopathic Pulmonary Fibrosis | 10 | 2023 | 467 | 2.760 |
Why?
| Pulmonary Fibrosis | 12 | 2019 | 310 | 2.030 |
Why?
| Lung | 23 | 2022 | 3865 | 2.000 |
Why?
| Bleomycin | 13 | 2021 | 218 | 1.690 |
Why?
| Apoptosis | 16 | 2023 | 2553 | 1.450 |
Why?
| fas Receptor | 6 | 2020 | 96 | 1.450 |
Why?
| Arthritis, Experimental | 3 | 2018 | 130 | 1.280 |
Why?
| Fibroblasts | 12 | 2023 | 859 | 1.200 |
Why?
| Receptors, Tumor Necrosis Factor, Type I | 7 | 2010 | 79 | 1.140 |
Why?
| Macrophages | 15 | 2018 | 1333 | 1.030 |
Why?
| Signal Transduction | 17 | 2020 | 4809 | 0.970 |
Why?
| Receptors, Tumor Necrosis Factor | 5 | 2005 | 148 | 0.930 |
Why?
| Tumor Necrosis Factor-alpha | 10 | 2014 | 1198 | 0.900 |
Why?
| Insulin-Like Growth Factor I | 5 | 2009 | 303 | 0.880 |
Why?
| Trans-Activators | 4 | 2015 | 383 | 0.860 |
Why?
| Lung Injury | 3 | 2019 | 213 | 0.860 |
Why?
| Mice | 43 | 2023 | 15984 | 0.780 |
Why?
| Collagen | 5 | 2018 | 443 | 0.770 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 2 | 2018 | 6 | 0.750 |
Why?
| Epithelial Cells | 8 | 2023 | 1005 | 0.740 |
Why?
| Macrophages, Alveolar | 3 | 2014 | 363 | 0.740 |
Why?
| Immunity, Innate | 4 | 2018 | 759 | 0.730 |
Why?
| TRPC Cation Channels | 2 | 2010 | 11 | 0.730 |
Why?
| Alveolar Epithelial Cells | 5 | 2023 | 98 | 0.680 |
Why?
| Indoles | 2 | 2019 | 327 | 0.650 |
Why?
| Animals | 49 | 2023 | 34345 | 0.650 |
Why?
| Antigens, CD | 4 | 2004 | 466 | 0.600 |
Why?
| Lung Diseases, Interstitial | 4 | 2023 | 476 | 0.590 |
Why?
| Myofibroblasts | 1 | 2018 | 131 | 0.560 |
Why?
| Mice, Inbred C57BL | 18 | 2021 | 5102 | 0.520 |
Why?
| Mice, Knockout | 13 | 2020 | 2736 | 0.510 |
Why?
| Interleukin-4 | 3 | 2008 | 211 | 0.510 |
Why?
| Serum Response Factor | 1 | 2015 | 30 | 0.490 |
Why?
| Cells, Cultured | 15 | 2020 | 4159 | 0.470 |
Why?
| Pneumonia | 3 | 2018 | 610 | 0.460 |
Why?
| Arthritis, Rheumatoid | 2 | 2013 | 1001 | 0.460 |
Why?
| Mesoderm | 1 | 2015 | 142 | 0.460 |
Why?
| Mitogen-Activated Protein Kinase 1 | 2 | 2005 | 178 | 0.450 |
Why?
| TNF Receptor-Associated Factor 2 | 3 | 2010 | 8 | 0.440 |
Why?
| NF-kappa B | 5 | 2009 | 681 | 0.430 |
Why?
| Acute Lung Injury | 2 | 2017 | 319 | 0.420 |
Why?
| Disease Models, Animal | 6 | 2020 | 3823 | 0.400 |
Why?
| Dendritic Cells | 2 | 2013 | 445 | 0.390 |
Why?
| Monocytes | 5 | 2018 | 523 | 0.390 |
Why?
| Receptor, Muscarinic M1 | 1 | 2010 | 2 | 0.370 |
Why?
| Cell Line | 10 | 2019 | 2806 | 0.370 |
Why?
| Transforming Growth Factor beta | 5 | 2020 | 457 | 0.360 |
Why?
| Up-Regulation | 4 | 2012 | 895 | 0.350 |
Why?
| Adaptive Immunity | 1 | 2011 | 163 | 0.350 |
Why?
| Testosterone | 1 | 2013 | 357 | 0.340 |
Why?
| X-Ray Microtomography | 2 | 2021 | 75 | 0.340 |
Why?
| Silicosis | 2 | 2023 | 22 | 0.340 |
Why?
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 21 | 0.330 |
Why?
| Lung Compliance | 3 | 2014 | 51 | 0.310 |
Why?
| JNK Mitogen-Activated Protein Kinases | 3 | 2011 | 156 | 0.310 |
Why?
| Interleukin-13 | 2 | 2010 | 134 | 0.300 |
Why?
| Phagocytosis | 5 | 2012 | 364 | 0.290 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 2 | 2020 | 20 | 0.290 |
Why?
| Autoimmunity | 1 | 2013 | 835 | 0.290 |
Why?
| Transcription Factor AP-1 | 2 | 2006 | 84 | 0.280 |
Why?
| Lung Diseases | 1 | 2013 | 768 | 0.270 |
Why?
| Inflammation Mediators | 3 | 2018 | 515 | 0.260 |
Why?
| Membrane Microdomains | 2 | 2004 | 35 | 0.260 |
Why?
| Th2 Cells | 2 | 2004 | 167 | 0.260 |
Why?
| Granulomatous Disease, Chronic | 3 | 2010 | 61 | 0.250 |
Why?
| Sodium Chloride | 1 | 2006 | 154 | 0.250 |
Why?
| Chemokines | 1 | 2006 | 232 | 0.250 |
Why?
| Proline | 1 | 2005 | 71 | 0.240 |
Why?
| 5' Untranslated Regions | 1 | 2005 | 52 | 0.240 |
Why?
| Respiratory Mucosa | 4 | 2019 | 264 | 0.240 |
Why?
| Flow Cytometry | 3 | 2020 | 1108 | 0.240 |
Why?
| Calcium | 1 | 2010 | 1211 | 0.240 |
Why?
| Humans | 37 | 2023 | 125131 | 0.240 |
Why?
| Interferon-gamma | 4 | 2010 | 749 | 0.230 |
Why?
| Keratin-8 | 1 | 2023 | 5 | 0.230 |
Why?
| Dual Specificity Phosphatase 1 | 3 | 2012 | 31 | 0.230 |
Why?
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2003 | 7 | 0.230 |
Why?
| Transcription, Genetic | 4 | 2014 | 1376 | 0.220 |
Why?
| Cytokines | 5 | 2018 | 1927 | 0.220 |
Why?
| Precancerous Conditions | 1 | 2004 | 166 | 0.220 |
Why?
| Gene Expression Regulation | 4 | 2010 | 2492 | 0.210 |
Why?
| Adenoma | 1 | 2004 | 194 | 0.210 |
Why?
| Stem Cells | 2 | 2019 | 570 | 0.210 |
Why?
| Neutrophils | 4 | 2018 | 1250 | 0.200 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 199 | 0.200 |
Why?
| Gene Expression Profiling | 4 | 2020 | 1642 | 0.200 |
Why?
| Promoter Regions, Genetic | 2 | 2008 | 1195 | 0.190 |
Why?
| Proteins | 4 | 2004 | 951 | 0.190 |
Why?
| Cell Communication | 2 | 2018 | 282 | 0.180 |
Why?
| Pulmonary Alveoli | 2 | 2017 | 399 | 0.180 |
Why?
| Mice, Mutant Strains | 3 | 2011 | 289 | 0.180 |
Why?
| Transcription Factors | 3 | 2011 | 1604 | 0.180 |
Why?
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 632 | 0.180 |
Why?
| Male | 16 | 2021 | 60792 | 0.180 |
Why?
| Endoplasmic Reticulum | 3 | 2011 | 249 | 0.170 |
Why?
| Mice, Inbred C3H | 3 | 2005 | 259 | 0.170 |
Why?
| Smoke | 2 | 2011 | 146 | 0.170 |
Why?
| Lymph Nodes | 2 | 2013 | 467 | 0.170 |
Why?
| Fibroblast Growth Factor 10 | 1 | 2019 | 22 | 0.170 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 20 | 0.170 |
Why?
| Mice, Transgenic | 4 | 2019 | 2061 | 0.170 |
Why?
| Enzyme Activation | 5 | 2011 | 863 | 0.160 |
Why?
| Molecular Sequence Data | 4 | 2010 | 2926 | 0.160 |
Why?
| Single-Cell Analysis | 1 | 2020 | 200 | 0.160 |
Why?
| Transfection | 3 | 2009 | 923 | 0.160 |
Why?
| Drug Resistance, Microbial | 1 | 2018 | 69 | 0.160 |
Why?
| Tissue Culture Techniques | 1 | 2018 | 70 | 0.160 |
Why?
| Case-Control Studies | 3 | 2018 | 3326 | 0.150 |
Why?
| Biopsy, Needle | 1 | 2018 | 191 | 0.150 |
Why?
| Down-Regulation | 2 | 2018 | 652 | 0.150 |
Why?
| Cell Differentiation | 3 | 2023 | 1778 | 0.150 |
Why?
| Lipopolysaccharides | 4 | 2012 | 870 | 0.150 |
Why?
| Sex Characteristics | 2 | 2013 | 699 | 0.150 |
Why?
| COS Cells | 4 | 2005 | 190 | 0.140 |
Why?
| Imaging, Three-Dimensional | 1 | 2021 | 554 | 0.140 |
Why?
| Mice, Inbred BALB C | 3 | 2011 | 1233 | 0.140 |
Why?
| Mutagenesis, Site-Directed | 2 | 2010 | 369 | 0.140 |
Why?
| Homeostasis | 1 | 2020 | 605 | 0.140 |
Why?
| Reference Values | 1 | 2018 | 818 | 0.140 |
Why?
| Disease Progression | 2 | 2021 | 2577 | 0.140 |
Why?
| Female | 12 | 2019 | 64889 | 0.140 |
Why?
| Fibrosis | 2 | 2019 | 497 | 0.140 |
Why?
| Lung Neoplasms | 2 | 2009 | 2244 | 0.140 |
Why?
| Phosphorylation | 6 | 2020 | 1694 | 0.130 |
Why?
| RNA, Small Interfering | 1 | 2018 | 584 | 0.130 |
Why?
| Hydrogels | 1 | 2022 | 608 | 0.130 |
Why?
| NADPH Oxidases | 3 | 2010 | 139 | 0.130 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 249 | 0.130 |
Why?
| Electrophoretic Mobility Shift Assay | 2 | 2006 | 80 | 0.130 |
Why?
| Extracellular Matrix | 2 | 2019 | 462 | 0.130 |
Why?
| Permeability | 2 | 2017 | 155 | 0.120 |
Why?
| Fas Ligand Protein | 2 | 2013 | 60 | 0.120 |
Why?
| TNF Receptor-Associated Factor 1 | 3 | 2003 | 11 | 0.120 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 837 | 0.120 |
Why?
| Blotting, Western | 6 | 2015 | 1233 | 0.120 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2009 | 291 | 0.120 |
Why?
| Extracellular Vesicles | 1 | 2015 | 80 | 0.120 |
Why?
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 6 | 0.120 |
Why?
| Hydroxyproline | 1 | 2014 | 23 | 0.120 |
Why?
| Cell Membrane | 2 | 2010 | 732 | 0.120 |
Why?
| Tacrolimus Binding Proteins | 1 | 2014 | 16 | 0.120 |
Why?
| Binding Sites | 2 | 2010 | 1248 | 0.120 |
Why?
| Gene Expression | 3 | 2012 | 1528 | 0.120 |
Why?
| Immunohistochemistry | 1 | 2018 | 1743 | 0.110 |
Why?
| Recombinant Proteins | 2 | 2010 | 1327 | 0.110 |
Why?
| Sequence Deletion | 2 | 2005 | 178 | 0.110 |
Why?
| Remission Induction | 1 | 2014 | 258 | 0.110 |
Why?
| Amino Acid Sequence | 2 | 2010 | 2098 | 0.110 |
Why?
| Proteolysis | 1 | 2013 | 150 | 0.110 |
Why?
| Transcriptional Activation | 2 | 2005 | 363 | 0.100 |
Why?
| Delayed-Action Preparations | 1 | 2012 | 163 | 0.100 |
Why?
| Cell Lineage | 1 | 2013 | 322 | 0.100 |
Why?
| GTPase-Activating Proteins | 1 | 2012 | 74 | 0.100 |
Why?
| Pyridones | 1 | 2012 | 120 | 0.100 |
Why?
| Matrix Metalloproteinase 3 | 1 | 2011 | 23 | 0.100 |
Why?
| Ventilator-Induced Lung Injury | 1 | 2012 | 53 | 0.100 |
Why?
| Chemokine CXCL1 | 1 | 2011 | 69 | 0.100 |
Why?
| Interleukin-8 | 2 | 2009 | 254 | 0.090 |
Why?
| Wound Healing | 2 | 2017 | 298 | 0.090 |
Why?
| Oxidative Stress | 3 | 2015 | 1210 | 0.090 |
Why?
| Protein Structure, Tertiary | 2 | 2005 | 836 | 0.090 |
Why?
| Cell Line, Transformed | 1 | 2011 | 143 | 0.090 |
Why?
| Orthomyxoviridae Infections | 1 | 2011 | 56 | 0.090 |
Why?
| Macrophage Activation | 2 | 2009 | 163 | 0.090 |
Why?
| Trauma Severity Indices | 1 | 2011 | 131 | 0.090 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2011 | 98 | 0.090 |
Why?
| Chemokine CXCL2 | 2 | 2010 | 46 | 0.090 |
Why?
| Endocytosis | 1 | 2011 | 157 | 0.090 |
Why?
| Schistosoma mansoni | 1 | 2010 | 40 | 0.090 |
Why?
| Antigen Presentation | 1 | 2011 | 194 | 0.090 |
Why?
| Protein Transport | 3 | 2011 | 419 | 0.090 |
Why?
| Recovery of Function | 1 | 2014 | 620 | 0.090 |
Why?
| Schistosomiasis | 1 | 2010 | 37 | 0.090 |
Why?
| MAP Kinase Signaling System | 1 | 2012 | 304 | 0.090 |
Why?
| Autophagy | 1 | 2013 | 323 | 0.090 |
Why?
| Granuloma | 1 | 2010 | 93 | 0.090 |
Why?
| Cell Proliferation | 3 | 2017 | 2333 | 0.090 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 304 | 0.090 |
Why?
| Peritonitis | 1 | 2010 | 80 | 0.090 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 144 | 0.090 |
Why?
| RNA, Messenger | 3 | 2011 | 2753 | 0.090 |
Why?
| Mitochondria | 1 | 2015 | 823 | 0.090 |
Why?
| NIH 3T3 Cells | 2 | 2014 | 141 | 0.080 |
Why?
| Antigens | 1 | 2011 | 324 | 0.080 |
Why?
| HeLa Cells | 3 | 2013 | 607 | 0.080 |
Why?
| Thiazolidinediones | 1 | 2010 | 154 | 0.080 |
Why?
| PPAR gamma | 1 | 2010 | 190 | 0.080 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2009 | 112 | 0.080 |
Why?
| Drug Delivery Systems | 1 | 2012 | 309 | 0.080 |
Why?
| Elastin | 1 | 2009 | 78 | 0.080 |
Why?
| MicroRNAs | 1 | 2015 | 660 | 0.080 |
Why?
| Nanoparticles | 1 | 2012 | 328 | 0.080 |
Why?
| Intubation, Intratracheal | 1 | 2011 | 240 | 0.080 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 168 | 0.080 |
Why?
| DEAD-box RNA Helicases | 1 | 2009 | 59 | 0.080 |
Why?
| Vitamin D | 1 | 2012 | 362 | 0.080 |
Why?
| Myoblasts | 1 | 2009 | 82 | 0.080 |
Why?
| Superoxide Dismutase | 1 | 2010 | 349 | 0.080 |
Why?
| Phosphatidylserines | 1 | 2008 | 91 | 0.080 |
Why?
| Glucocorticoids | 2 | 2012 | 554 | 0.080 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 400 | 0.080 |
Why?
| Respiration, Artificial | 1 | 2012 | 595 | 0.070 |
Why?
| Hypersensitivity | 1 | 2011 | 265 | 0.070 |
Why?
| Asthma | 2 | 2012 | 2150 | 0.070 |
Why?
| Receptors, Cell Surface | 1 | 2009 | 368 | 0.070 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2008 | 57 | 0.070 |
Why?
| Prednisone | 1 | 2008 | 236 | 0.070 |
Why?
| Interleukin-1beta | 1 | 2009 | 382 | 0.070 |
Why?
| DNA-Binding Proteins | 2 | 2005 | 1373 | 0.070 |
Why?
| Survival Rate | 1 | 2011 | 1799 | 0.070 |
Why?
| Models, Biological | 2 | 2013 | 1753 | 0.070 |
Why?
| Cell Survival | 2 | 2013 | 1081 | 0.070 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2009 | 437 | 0.070 |
Why?
| Genetic Vectors | 2 | 2011 | 315 | 0.070 |
Why?
| Vaccines | 1 | 2011 | 380 | 0.070 |
Why?
| Fas-Associated Death Domain Protein | 1 | 2005 | 17 | 0.070 |
Why?
| Sex Factors | 1 | 2011 | 1901 | 0.060 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2004 | 307 | 0.060 |
Why?
| Consensus Sequence | 1 | 2005 | 71 | 0.060 |
Why?
| Metalloendopeptidases | 1 | 2005 | 57 | 0.060 |
Why?
| Asparagine | 1 | 2005 | 32 | 0.060 |
Why?
| Sp3 Transcription Factor | 1 | 2005 | 6 | 0.060 |
Why?
| Nitric Oxide | 1 | 2010 | 886 | 0.060 |
Why?
| Inflammation | 4 | 2012 | 2612 | 0.060 |
Why?
| Base Sequence | 2 | 2009 | 2207 | 0.060 |
Why?
| Colorado | 1 | 2015 | 4471 | 0.060 |
Why?
| Luciferases | 1 | 2005 | 154 | 0.060 |
Why?
| Serine | 1 | 2005 | 143 | 0.060 |
Why?
| Growth Substances | 1 | 2004 | 139 | 0.060 |
Why?
| Amino Acid Substitution | 1 | 2005 | 279 | 0.060 |
Why?
| Cytoplasm | 1 | 2005 | 276 | 0.060 |
Why?
| Hyperplasia | 1 | 2004 | 171 | 0.060 |
Why?
| Culture Media, Conditioned | 1 | 2004 | 112 | 0.060 |
Why?
| Point Mutation | 1 | 2005 | 236 | 0.060 |
Why?
| Antibiotics, Antineoplastic | 1 | 2004 | 118 | 0.060 |
Why?
| Longitudinal Studies | 1 | 2011 | 2669 | 0.060 |
Why?
| rac GTP-Binding Proteins | 1 | 2004 | 36 | 0.060 |
Why?
| TNF Receptor-Associated Death Domain Protein | 1 | 2003 | 3 | 0.060 |
Why?
| CD36 Antigens | 1 | 2004 | 42 | 0.060 |
Why?
| Exons | 1 | 2005 | 316 | 0.060 |
Why?
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2003 | 19 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 1008 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 158 | 0.060 |
Why?
| Age Factors | 1 | 2011 | 3152 | 0.060 |
Why?
| STAT6 Transcription Factor | 1 | 2003 | 22 | 0.060 |
Why?
| STAT1 Transcription Factor | 1 | 2003 | 68 | 0.050 |
Why?
| Time Factors | 1 | 2014 | 6780 | 0.050 |
Why?
| Silicon Dioxide | 1 | 2003 | 100 | 0.050 |
Why?
| Drug Synergism | 1 | 2003 | 344 | 0.050 |
Why?
| Protein Processing, Post-Translational | 1 | 2005 | 420 | 0.050 |
Why?
| Cloning, Molecular | 1 | 2003 | 566 | 0.050 |
Why?
| Thorax | 1 | 2022 | 53 | 0.050 |
Why?
| Adenoviridae | 2 | 2014 | 196 | 0.050 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2023 | 202 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 233 | 0.050 |
Why?
| Jurkat Cells | 2 | 2013 | 136 | 0.050 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2009 | 2135 | 0.050 |
Why?
| Rats | 3 | 2017 | 5517 | 0.050 |
Why?
| Gene Deletion | 2 | 2014 | 362 | 0.050 |
Why?
| Kinetics | 1 | 2004 | 1680 | 0.050 |
Why?
| Proto-Oncogene Proteins | 1 | 2004 | 656 | 0.050 |
Why?
| Genetic Predisposition to Disease | 1 | 2009 | 2382 | 0.040 |
Why?
| NADPH Oxidase 2 | 2 | 2010 | 42 | 0.040 |
Why?
| Obesity | 1 | 2012 | 2805 | 0.040 |
Why?
| Prospective Studies | 1 | 2011 | 6818 | 0.040 |
Why?
| Middle Aged | 3 | 2012 | 29112 | 0.040 |
Why?
| Hypertension, Pulmonary | 1 | 2010 | 1880 | 0.040 |
Why?
| Aged | 2 | 2009 | 20859 | 0.040 |
Why?
| Scleroderma, Systemic | 1 | 2019 | 99 | 0.040 |
Why?
| Dexamethasone | 2 | 2012 | 329 | 0.040 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 785 | 0.040 |
Why?
| Regeneration | 1 | 2019 | 177 | 0.040 |
Why?
| p38 Mitogen-Activated Protein Kinases | 2 | 2012 | 292 | 0.040 |
Why?
| Reactive Oxygen Species | 2 | 2010 | 593 | 0.040 |
Why?
| Membrane Glycoproteins | 2 | 2010 | 454 | 0.040 |
Why?
| Chemokine CXCL12 | 1 | 2017 | 79 | 0.040 |
Why?
| Receptors, CXCR4 | 1 | 2017 | 81 | 0.040 |
Why?
| Rats, Sprague-Dawley | 2 | 2012 | 2512 | 0.030 |
Why?
| Enzyme Induction | 2 | 2008 | 95 | 0.030 |
Why?
| Anti-Inflammatory Agents | 1 | 2019 | 471 | 0.030 |
Why?
| Arrestins | 1 | 2015 | 17 | 0.030 |
Why?
| Toll-Like Receptor 9 | 1 | 2015 | 29 | 0.030 |
Why?
| Microscopy, Electron | 1 | 2015 | 420 | 0.030 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2015 | 97 | 0.030 |
Why?
| Cell-Derived Microparticles | 1 | 2015 | 62 | 0.030 |
Why?
| Toll-Like Receptors | 1 | 2015 | 170 | 0.030 |
Why?
| Actins | 2 | 2009 | 410 | 0.030 |
Why?
| Exosomes | 1 | 2015 | 92 | 0.030 |
Why?
| Receptors, Immunologic | 1 | 2015 | 213 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2022 | 2848 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2017 | 537 | 0.030 |
Why?
| Smad Proteins | 1 | 2014 | 38 | 0.030 |
Why?
| Sequestosome-1 Protein | 1 | 2013 | 18 | 0.030 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 52 | 0.030 |
Why?
| Protein Binding | 2 | 2013 | 2014 | 0.030 |
Why?
| Antigens, Ly | 1 | 2013 | 47 | 0.030 |
Why?
| Protein Kinase Inhibitors | 1 | 2019 | 832 | 0.030 |
Why?
| Culture Media | 1 | 2013 | 164 | 0.030 |
Why?
| Chloroquine | 1 | 2013 | 63 | 0.030 |
Why?
| Risk Factors | 2 | 2022 | 9549 | 0.030 |
Why?
| Young Adult | 1 | 2009 | 11384 | 0.030 |
Why?
| Genes, Reporter | 1 | 2014 | 274 | 0.030 |
Why?
| Polyglactin 910 | 1 | 2012 | 10 | 0.030 |
Why?
| PPAR delta | 1 | 2012 | 6 | 0.030 |
Why?
| Endothelium | 1 | 2013 | 120 | 0.030 |
Why?
| Receptors, Chemokine | 1 | 2012 | 46 | 0.030 |
Why?
| Cyclooxygenase 2 | 1 | 2013 | 171 | 0.030 |
Why?
| Toll-Like Receptor 4 | 1 | 2015 | 333 | 0.030 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2009 | 3471 | 0.030 |
Why?
| Bronchoalveolar Lavage | 1 | 2012 | 98 | 0.030 |
Why?
| Diterpenes | 1 | 2012 | 34 | 0.030 |
Why?
| Supine Position | 1 | 2012 | 46 | 0.030 |
Why?
| Prone Position | 1 | 2012 | 52 | 0.020 |
Why?
| Green Fluorescent Proteins | 1 | 2013 | 401 | 0.020 |
Why?
| I-kappa B Proteins | 1 | 2012 | 82 | 0.020 |
Why?
| Mice, 129 Strain | 1 | 2012 | 77 | 0.020 |
Why?
| Histocompatibility Antigens Class II | 1 | 2013 | 356 | 0.020 |
Why?
| Caspase 12 | 1 | 2011 | 1 | 0.020 |
Why?
| Thapsigargin | 1 | 2011 | 18 | 0.020 |
Why?
| Aldehydes | 1 | 2012 | 173 | 0.020 |
Why?
| Staurosporine | 1 | 2011 | 24 | 0.020 |
Why?
| Receptors, Glucocorticoid | 1 | 2012 | 136 | 0.020 |
Why?
| Instillation, Drug | 1 | 2011 | 8 | 0.020 |
Why?
| Cyclin D1 | 1 | 2011 | 63 | 0.020 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2011 | 59 | 0.020 |
Why?
| Phenotype | 1 | 2019 | 3153 | 0.020 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2011 | 129 | 0.020 |
Why?
| Onium Compounds | 1 | 2010 | 13 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2012 | 276 | 0.020 |
Why?
| Recombinant Fusion Proteins | 1 | 2013 | 658 | 0.020 |
Why?
| Sputum | 1 | 2012 | 293 | 0.020 |
Why?
| Zymosan | 1 | 2010 | 64 | 0.020 |
Why?
| Smad3 Protein | 1 | 2010 | 46 | 0.020 |
Why?
| Smad2 Protein | 1 | 2010 | 38 | 0.020 |
Why?
| Adolescent | 1 | 2009 | 19411 | 0.020 |
Why?
| Cadherins | 1 | 2011 | 190 | 0.020 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 299 | 0.020 |
Why?
| Endomyocardial Fibrosis | 1 | 2009 | 3 | 0.020 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2011 | 178 | 0.020 |
Why?
| Ventricular Pressure | 1 | 2009 | 42 | 0.020 |
Why?
| Janus Kinase 2 | 1 | 2009 | 35 | 0.020 |
Why?
| Stress Fibers | 1 | 2009 | 18 | 0.020 |
Why?
| Amiloride | 1 | 2009 | 26 | 0.020 |
Why?
| STAT5 Transcription Factor | 1 | 2009 | 48 | 0.020 |
Why?
| Survivors | 1 | 2013 | 460 | 0.020 |
Why?
| beta Catenin | 1 | 2011 | 231 | 0.020 |
Why?
| Viral Load | 1 | 2011 | 426 | 0.020 |
Why?
| Immunoenzyme Techniques | 1 | 2009 | 201 | 0.020 |
Why?
| Receptors, IgG | 1 | 2009 | 68 | 0.020 |
Why?
| rhoA GTP-Binding Protein | 1 | 2009 | 81 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2012 | 1042 | 0.020 |
Why?
| Interferon-Induced Helicase, IFIH1 | 1 | 2009 | 14 | 0.020 |
Why?
| RNA Splice Sites | 1 | 2009 | 40 | 0.020 |
Why?
| Cell Movement | 1 | 2013 | 913 | 0.020 |
Why?
| Codon, Nonsense | 1 | 2009 | 38 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2009 | 415 | 0.020 |
Why?
| Skin | 1 | 2013 | 698 | 0.020 |
Why?
| Receptors, Interleukin-1 | 1 | 2009 | 230 | 0.020 |
Why?
| Linkage Disequilibrium | 1 | 2009 | 288 | 0.020 |
Why?
| Drug Resistance | 1 | 2008 | 170 | 0.020 |
Why?
| Stress, Mechanical | 1 | 2009 | 456 | 0.020 |
Why?
| Gene Frequency | 1 | 2009 | 528 | 0.020 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2008 | 171 | 0.020 |
Why?
| Analysis of Variance | 1 | 2010 | 1366 | 0.020 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 841 | 0.020 |
Why?
| Risk | 1 | 2009 | 896 | 0.020 |
Why?
| Sequence Analysis, DNA | 1 | 2009 | 767 | 0.020 |
Why?
| COP-Coated Vesicles | 1 | 2005 | 2 | 0.020 |
Why?
| ADAM17 Protein | 1 | 2005 | 33 | 0.020 |
Why?
| Threonine | 1 | 2005 | 48 | 0.020 |
Why?
| Myocytes, Cardiac | 1 | 2009 | 487 | 0.020 |
Why?
| ADAM Proteins | 1 | 2005 | 60 | 0.020 |
Why?
| Golgi Apparatus | 1 | 2005 | 96 | 0.020 |
Why?
| Adult | 3 | 2012 | 33167 | 0.020 |
Why?
| Interleukin-6 | 1 | 2008 | 710 | 0.010 |
Why?
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2004 | 4 | 0.010 |
Why?
| Erythrocytes | 1 | 2009 | 642 | 0.010 |
Why?
| Guanine Nucleotides | 1 | 2004 | 20 | 0.010 |
Why?
| Cell Surface Extensions | 1 | 2004 | 12 | 0.010 |
Why?
| Cell Size | 1 | 2004 | 87 | 0.010 |
Why?
| rac1 GTP-Binding Protein | 1 | 2004 | 58 | 0.010 |
Why?
| Genetic Variation | 1 | 2009 | 970 | 0.010 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2004 | 61 | 0.010 |
Why?
| Cytoskeleton | 1 | 2004 | 183 | 0.010 |
Why?
| Cohort Studies | 1 | 2012 | 5348 | 0.010 |
Why?
| Bone Marrow | 1 | 2004 | 259 | 0.010 |
Why?
| Biomarkers | 1 | 2012 | 3736 | 0.010 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1403 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 2004 | 419 | 0.010 |
Why?
| Quality of Life | 1 | 2013 | 2580 | 0.010 |
Why?
| Microtubules | 1 | 2004 | 246 | 0.010 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 1347 | 0.010 |
Why?
| Cystic Fibrosis | 1 | 2008 | 990 | 0.010 |
Why?
| Mutation | 1 | 2004 | 3520 | 0.010 |
Why?
| Child | 1 | 2008 | 20014 | 0.000 |
Why?
|
|
Riches's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|